Day to day across the SYNLAB globe, our scientists are researching, publishing and collaborating with partners in scientific excellence.
Either approaching or reaching immediate clinical utility, their work lays pivotal groundwork for advancement in disease prevention, diagnostics and decision support, treatment and patient quality of life.
Each year at the SYNLAB Congress, we recognise this commitment with our very own Medical Innovation Awards. Driven by customer needs, our 2021 awardees have contributed to medical excellence in the fields of
Turning scientific research into innovative services and products starts with the compound of an idea and the willingness to think it further, refine and transform it. This page introduces you to our award recipients, their publications—and inspirations.
WOMEN’S HEALTH
SYNLAB Italy
Dr Katia Pane
Bioinformatic and Biostatistic Unit, SYNLAB IRCCS SDN, Naples
An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers
Frontiers in Genetics – https://doi.org/10.3389/fgene.2020.612521
SYNLAB UK & Ireland
Dr Julia van Campen
Clinical Scientist, Molecular Genetics, Viapath (A partnership between the NHS and SYNLAB UK & Ireland) Guy’s and St. Thomas’ NHS Foundation Trust, London
A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies
British Journal of Haematology – https://doi.org/10.1111/bjh.16529
CARDIOVASCULAR
SYNLAB Germany
Dr rer. nat. Marcus Kleber
SYNLAB MVZ Humangenetik Mannheim, Zentrum für Humangenetik Mannheim (ZHMA)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
European Heart Journal – https://doi.org/10.1093/eurheartj/ehab107
ONCOLOGY
SYNLAB Italy
Dr Aldo Morra
Radiologist, Director of SYNLAB Euganea Medica, Padua, IRCCS SDN-SYNLAB Naples
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study
Lancet Respiratory Medicine – https://doi.org/10.1016/S2213-2600(21)00043-6
SYNLAB Italy
Dr Ornella Affinito
Bioinformatics and Biostatistics Unit, SYNLAB IRCCS SDN, Naples
lncRNAs-mRNAs Co-Expression Network Underlying Childhood B-Cell Acute Lymphoblastic Leukaemia: A Pilot Study
Cancers – https://doi.org/10.3390/cancers12092489
LABORATORY SCIENCE
SYNLAB UK & Ireland
Dr Penelope R. Cliff
Lead Clinical Scientist, Infection Sciences, Viapath (A partnership between the NHS and SYNLAB UK & Ireland)
St Thomas’ Hospital, London
Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unit
Journal of Infection – https://doi.org/10.1016/j.jinf.2021.06.014
SYNLAB Italy
Dr Giovanni Smaldone
Senior Researcher, SYNLAB IRCCS SDN, Naples
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth
Biomarker Research – https://doi.org/10.1186/s40364-021-00307-7
IT/AI IN DIAGNOSTICS
SYNLAB Spain
MSc Laura Bigorra
Clinical Pathologist, Haematology Department, SYNLAB Global Diagnostics, Barcelona
Abnormal characteristic “round bottom flask” shape volume-based scattergram as a trigger to suspect persistent polyclonal B-cell lymphocytosis
Clinica Chimica Acta – https://doi.org/10.1016/j.cca.2020.10.015
SYNLAB UK & Ireland
Dr Rachel S. Carling
Director of Newborn Screening and Clinical Lead, Biochemical SciencesScientific Director, Viapath (A partnership between the NHS and SYNLAB UK & Ireland) Guys & St Thomas’ NHS Foundation Trust, London
A Machine Learning Approach for the Automated Interpretation of Plasma Amino Acid Profiles
Clinical Chemistry – https://doi.org/10.1093/clinchem/hvaa134